The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
809
January 12, 1990
View Complete Issue         Table of Contents 2019 
Interferon for Chronic Viral Hepatitis
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Interferon for Chronic Viral Hepatitis
January 12, 1990 (Issue: 809)
Recombinant alpha interferon has been marketed in the USA for treatment of hairy-cell leukemia, genital warts, and AIDS-related Kaposi's sarcoma (Medical Letter, 28:78, 1986; 30:70, 1988). Recent reports indicate it may also be useful for treatment...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Interferon for Chronic Viral Hepatitis
Article code: 809a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.